Chabra, Sanjay
Birt, Julie
Bolce, Rebecca
Lisse, Jeffrey
Malatestinic, William N.
Zhu, Baojin
Kimel, Miriam
McCormack, Julie
Stefan, Marissa
Cragun, W. Chad
Funding for this research was provided by:
Eli Lilly and Company
Article History
Received: 28 November 2023
Accepted: 2 February 2024
First Online: 5 March 2024
Declarations
:
: Julie Birt, Rebecca Bolce, Jeffrey Lisse, William N. Malatestinic, and Baojin Zhu are employees of Eli Lilly and Company and hold stock in the company. Sanjay Chabra has served as speaker for Eli Lilly and Company. W. Chad Cragun has served as advisor and speaker for Eli Lilly and Company. Miriam Kimel, Julie McCormack, and Marissa Stefan are employees of Evidera Inc.
: This study was conducted in accordance with the ethical principles based on the Declaration of Helsinki and was approved by an institutional review board (Advarra CIRBITM; Pro00065375) on 05 August 2022. All participants provided informed consent electronically.